Cogent Biosciences Inc (COGT)
$31.02 -2.94% Close Oct 30, 2026 Live
Cogent Biosciences stock today
Cogent Biosciences closed at $31.02 on October 30, 2026, down 2.94% on the day. Over the past year it returned +91.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.30 billion.
$20.00$30.00$40.00
NovJan 2026MarMayJulSep
| Period | COGT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.1% | -0.9% |
| 3 months | -25.0% | +2.1% |
| Year to date | -12.7% | +11.7% |
| 1 year | +91.4% | +12.4% |
| 3 years | +275.5% | +88.5% |
| 5 years | +265.8% | +76.0% |
Key statistics
- Market value
- $5.30B
- 52-week range
- $14.13 to $42.84
- Next report
- Nov 3, 2026 (estimated)
About Cogent Biosciences
Develops small-molecule therapeutics for oncology and blood disorders.
Sector: Health Care
More on Cogent Biosciences
- Financials: revenue, earnings and segmentsRevenue -65% in the year to Dec 2020
- Returns: what $1,000 became$1,000 five years ago is $3,658 today
No forecast, no recommendation. This page describes Cogent Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.